SCYX: the cashflow

MyFinsight

For the quarter ending 2025-09-30, SCYX had $3,722K increase in cash & cash equivalents over the period.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net loss	-8,591	-12,276
Stock-based compensation expense	526	1,639
Accretion of investment discount	98	314
Amortization of debt issuance costs and discount	0	312
Change in fair value of warrant liability	640	-5,094
Change in fair value of derivative liability	0	0
Noncash operating lease expense for right-of-use asset	83	156
Prepaid expenses, other assets, deferred costs, and other	-942	-803
License agreement receivable	0	9,247
License agreement contract asset	0	-9,509
Accounts payable	-2,705	1,713
Accrued expenses	297	-1,316
Deferred revenue	287	-652
Other liabilities	-105	-193
Net cash used in operating activities	-8,724	-14,960
Purchase of investments	0	0
Maturity of investments	12,417	23,713
Net cash provided by investing activities	12,417	23,713
Proceeds from common stock issued	4	-
Payment of convertible debt	0	14,000
Payment of deferred offering costs	0	110
Proceeds from employee stock purchase plan issuances	25	26
Net cash (used in) provided by financing activities	29	-14,084
Net decrease in cash, cash equivalents, and restricted cash	3,722	-5,331
Cash and cash equivalents at beginning of period	16,595	-
Cash and cash equivalents at end of period	14,986	-

Unit: Thousand (K) dollars